VERELAN PM 300 mg/1
verapamil hydrochloride · CAPSULE, EXTENDED RELEASE · Lannett Company, Inc.
Verelan PM is a prescription medication containing verapamil hydrochloride, a calcium channel blocker used to treat high blood pressure and certain heart rhythm disorders. This extended-release capsule is designed to be taken by mouth once daily, typically in the evening.
Key Facts
- Brand Name
- VERELAN PM
- Generic Name
- verapamil hydrochloride
- NDC Code (Product)
62175-572- Manufacturer
- Lannett Company, Inc.
- Strength
- 300 mg/1
- Dosage Form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA020943
- Marketing Start
- 11/25/1998
Recall History
No Recall HistoryFrequently Asked Questions
What is VERELAN PM used for?
Verelan PM is a prescription medication containing verapamil hydrochloride, a calcium channel blocker used to treat high blood pressure and certain heart rhythm disorders. This extended-release capsule is designed to be taken by mouth once daily, typically in the evening.
Is VERELAN PM a controlled substance?
VERELAN PM is not classified as a controlled substance by the DEA.
What is the generic name for VERELAN PM?
The generic name for VERELAN PM is verapamil hydrochloride. There are 11 other brand versions of verapamil hydrochloride.
What is the NDC code for VERELAN PM 300 mg/1?
The NDC (National Drug Code) for VERELAN PM 300 mg/1 is 62175-572, listed by Lannett Company, Inc..
Other VERELAN PM Dosages
Other Verapamil Brands
See all →- verapamil hydrochloride180 mg/172789-416
- Verapamil Hydrochloride2.5 mg/mL42571-313
- Verapamil Hydrochloride2.5 mg/mL43066-035
- verapamil hydrochloride180 mg/151655-959
- Verapamil Hydrochloride2.5 mg/mL65145-113
- VERAPAMIL HYDROCHLORIDE120 mg/168788-8338
- Verapamil Hydrochloride2.5 mg/mL70121-1586
- Verapamil Hydrochloride120 mg/10378-6320
- Verapamil Hydrochloride2.5 mg/mL70518-4453
- verapamil hydrochloride2.5 mg/mL70756-606
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)